Weight Loss and Interleukin 6 in Lung Cancer
Author Information
Author(s): HR Scott, DC McMillan, A Crilly, CS McArdle, R Milroy
Primary Institution: Stobhil NHS Trust and Royal Infirmary, Glasgow, UK
Hypothesis
Does interleukin 6 play a role in weight loss among non-small-cell lung cancer patients?
Conclusion
The study found that interleukin 6 levels were higher in lung cancer patients who experienced significant weight loss.
Supporting Evidence
- Patients with weight loss had significantly higher levels of interleukin 6.
- There was a strong correlation between interleukin 6 and C-reactive protein levels.
- Weight loss in lung cancer patients is associated with an active acute phase response.
Takeaway
This study shows that when lung cancer patients lose weight, a substance called interleukin 6 in their blood goes up, which might be making them lose weight.
Methodology
Patients with and without weight loss were studied, measuring various blood parameters and interleukin 6 levels.
Limitations
The study had a small sample size and was limited to patients without infections or prior treatments.
Participant Demographics
Patients were diagnosed with non-small-cell lung cancer, with a mix of sexes and ages ranging from 51 to 83 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website